Moreover, inhibition of CERK counteracted chemoresistance in the breast cancer cells through a mechanism involving activation of the Ras/ERK, PI3K/Akt/mTOR, and RhoA pathways [68,69]. This evidence concerns the gene AKT1 and breast carcinoma.